• / Free eNewsletters & Magazine
  • / My Account
Home>Companies>McKesson

McKesson

PIMCO Unconstrained Tax Managed Bd A ATMAX 2 Star

Last Price$10.32Day Change (%)-0.10%
Open Price$10.32Day Change ($)-0.01
Day Range10.32–10.3252-Week Range9.58–10.33

As of Fri 01/19/2017 | USD

  1. All
  2. Morningstar Articles
  3. 3rd Party
  1. McKesson settles probe over drug orders for $150 million

    McKesson settles probe over drug orders for $150 million

  2. McKesson to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders -- Update

    McKesson to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders -- Update

  3. McKesson to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders

    McKesson to Pay $150 Million for Failing to Report 'Suspicious' Drug Orders

  4. McKesson Completes Acquisition of Rexall Health and Appoints Domenic Pilla as CEO of McKesson Canada

    McKesson Completes Acquisition of Rexall Health and Appoints Domenic Pilla as CEO of McKesson Canada

  5. McKesson MCK Q4 2014 Earnings Call Transcript

    Good afternoon, everyone, and welcome to the McKesson Corporation Quarterly Earnings Call. All participants are in a listen-only mode. Today's call is being recorded. If you have any objections, you may disconnect at this time.

  6. McKesson Specialty Health and The US Oncology Network Invited to Participate in the Final White House “Making Health Care Better” Series Focused on Community Oncology

    McKesson Specialty Health and The US Oncology Network Invited to Participate in the Final White House “Making Health Care Better” Series Focused on Community Oncology

  7. $80.56 Billion Revenue Cycle Management (Integrated RCM, Standalone RCM) Market by Product, Component, Deployment, Geography - Global Forecast to 2021 - Research and Markets

    $80.56 Billion Revenue Cycle Management (Integrated RCM, Standalone RCM) Market by Product, Component, Deployment, Geography - Global Forecast to 2021 - Research and Markets

  8. NovaBay Pharmaceuticals Announces Preliminary Sales for the Fourth Quarter of 2016

    NovaBay Pharmaceuticals Announces Preliminary Sales for the Fourth Quarter of 2016

  9. Laboratory Informatics Market - Analysis By Product, Delivery Mode, Component, End Use & Segment Forecasts to 2025 - Research and Markets

    Laboratory Informatics Market - Analysis By Product, Delivery Mode, Component, End Use & Segment Forecasts to 2025 - Research and Markets

12
Upcoming Events
Conferences
Webinars

©2014 Morningstar Advisor. All right reserved.